NANJING MEIRUI PHARMA CO., LTD.
Nanjing MeiRui Pharma Co., Ltd. operates as a pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Sheniting for overactive bladder syndrome.
NANJING MEIRUI PHARMA CO., LTD.
Industry:
Health Care Pharmaceutical
Founded:
1996-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Contact:
+86 21 6288 0666
Similar Organizations
Kolon Pharma
Kolon Pharma is a pharmaceutical company that provides healthcare products.
Nanjing Hicin Pharmaceutical
Nanjing Hicin Pharmaceutical operates as a pharmaceutical company.
Pharos Indonesia
Pharos Indonesia is a pharmaceutical company which produces and sells pharmaceutical products.
More informations about "Nanjing MeiRui Pharma Co., Ltd."
Nanjing MeiRui Pharma Co., Ltd. - Crunchbase
Nanjing MeiRui Pharma Co., Ltd. operates as a pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Sheniting …See details»
GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals …
Dec 6, 2010 · Nanjing Merui Pharmaceuticals (MeiRui) is a Chinese pharmaceutical company specializing in manufacturing urology and allergy medicines in China. MeiRui is the China …See details»
Nanjing MeiRui Pharma - Ownership and Business Overview
Dec 6, 2010 · Nanjing MeiRui Pharma Co. Ltd. is a Chinese pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic …See details»
GSK to acquire Nanjing MeiRui Pharmaceuticals in China
Dec 9, 2010 · Nanjing Merui Pharmaceuticals (MeiRui) is a Chinese pharmaceutical company specializing in manufacturing urology and allergy medicines in China. MeiRui is the China …See details»
GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals
GlaxoSmithKline plc announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of approximately $70 million.See details»
Nanjing Meirui Pharma Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nanjing Meirui Pharma Co., Ltd. of Nanjing, Jiangsu. Get the latest business insights from Dun & Bradstreet.See details»
GSK Signs Agreement To Acquire Nanjing MeiRui Pharmaceuticals …
Dec 9, 2010 · GlaxoSmithKline plc (GSK) recently announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of …See details»
Nanjing MeiRui Pharma Co Ltd - Company Profile and News
Nanjing MeiRui Pharma Co., Ltd. manufactures drugs. The Company produces pushitai tablets, chenitin, and naftopidil tablets. Nanjing MeiRui Pharma markets its products throughout China.See details»
Nanjing MeiRui Pharma Co., Ltd. - Crunchbase
Nanjing MeiRui Pharma Co., Ltd. operates as a pharmaceutical business with a strong portfolio of urology and allergy products.See details»
GSK to acquire Nanjing MeiRui Pharmaceuticals in China - CPHI …
Dec 10, 2010 · GlaxoSmithKline plc (GSK) has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of approximately $70 million.See details»
Nanjing MeiRui Pharma Co., Ltd. acquired by GlaxoSmithKline
Nanjing MeiRui Pharma Co., Ltd. Nanjing MeiRui Pharma Co., Ltd. operates as a pharmaceutical business with a strong portfolio of urology and allergy products. Acquiring Organization: …See details»
GSK acquires China’s Nanjing MeiRui Pharma for $70m
Dec 8, 2010 · Nanjing MeiRui Pharma Co’s portfolio includes urology and allergy products, such as Prostat for benign prostatic hyperplasia (enlarged prostate) and SheNiTing for overactive …See details»
GSK to Acquire Nanjing MeiRui Pharmaceuticals in China for $70M
Dec 7, 2010 · an agreement to acquire Nanjing MeiRui Pharma Co., Ltd for a cash consideration of approximately $70 million. Ninety per cent of the share capital of MeiRui is to be acquired …See details»
GSK to acquire Chinese drug firm Nanjing MeiRui Pharma for $70 …
GlaxoSmithKline plc (GSK) announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of approximately $70 million.See details»
GSK buys China's MeiRui for $70M - Fierce Pharma
Dec 7, 2010 · With the acquisition, GSK gains MeiRui's portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Sheniting for overactive bladder …See details»
Acquisition agreement for Nanjing MeiRui Pharma
Pharmaceutical giant GlaxoSmithKline has reached a deal to buy China’s Nanjing MeiRui Pharma for $70 million in cash. Ninety per cent of the share capital of MeiRui is to be acquired from …See details»
GSK Acquires Nanjing MeiRui Pharma | Mergr M&A Deal Summary
Dec 6, 2010 · Nanjing MeiRui Pharma Co. Ltd. is a Chinese pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic …See details»
GlaxoSmithKline Expands into China with Nanjing MeiRui Pharma …
Dec 13, 2010 · GlaxoSmithKline (GSK) has acquired the Chinese pharmaceutical company Nanjing MeiRui Pharma for approximately US$70 M in cash, emphasising its focus on …See details»
Glaxo to Buy China’s MeiRui for $70 Million in Cash - Bloomberg
Dec 7, 2010 · GlaxoSmithKline Plc agreed to buy China’s Nanjing MeiRui Pharma Co. Ltd. for about $70 million in cash, increasing its share of a fast-growing market that is expected to …See details»
Nanjing MeiRui Pharma Co. Ltd | Insights
Latest on Nanjing MeiRui Pharma Co. Ltd. Already A Biomedtracker Subscriber? You have access to the full company record through your subscription. Go To Biomedtracker. ... a …See details»